Follow
Lars Pedersen
Lars Pedersen
Professor, University of Copenhagen
Verified email at lundbeck.com
Title
Cited by
Cited by
Year
Derivatives of erythropoietin that are tissue protective but not erythropoietic
M Leist, P Ghezzi, G Grasso, R Bianchi, P Villa, M Fratelli, C Savino, ...
Science 305 (5681), 239-242, 2004
10352004
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
S Erbayraktar, G Grasso, A Sfacteria, Q Xie, T Coleman, M Kreilgaard, ...
Proceedings of the National Academy of Sciences 100 (11), 6741-6746, 2003
5902003
Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients
MH Andersen, LØ Pedersen, JC Becker, P Straten
Cancer research 61 (3), 869-872, 2001
3652001
Spontaneous Cytotoxic T-Cell Responses against Survivin-derived MHC Class I-restricted T-Cell Epitopes in Situ As Well As ex Vivo in Cancer Patients
MH Andersen, LØ Pedersen, B Capeller, EB Bröcker, JC Becker, ...
Cancer research 61 (16), 5964-5968, 2001
3542001
Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial
H Davtyan, A Ghochikyan, I Petrushina, A Hovakimyan, A Davtyan, ...
Journal of Neuroscience 33 (11), 4923-4934, 2013
1832013
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
JK Ryu, VA Rafalski, A Meyer-Franke, RA Adams, SB Poda, ...
Nature immunology 19 (11), 1212-1223, 2018
1652018
T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides.
SL Larsen, LO Pedersen, S Buus, A Stryhn
The Journal of experimental medicine 184 (1), 183-189, 1996
1651996
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin
K Otto, MH Andersen, A Eggert, P Keikavoussi, LØ Pedersen, JC Rath, ...
Vaccine 23 (7), 884-889, 2005
1442005
Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and …
A Stryhn, LØ Pedersen, T Romme, CB Holm, A Holm, S Buus
European journal of immunology 26 (8), 1911-1918, 1996
1391996
Establishment of a quantitative ELISA capable of determining peptide–MHC class I interaction
C Sylvester‐Hvid, N Kristensen, T Blicher, H Ferre, SL Lauemøller, ...
Tissue antigens 59 (4), 251-258, 2002
1152002
Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin
G Bolt, LØ Pedersen, HH Birkeslund
Virus research 68 (1), 25-33, 2000
1012000
Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer’s disease: a translational study of neuropathological and inflammatory markers
T Schütt, L Helboe, LØ Pedersen, G Waldemar, M Berendt, JT Pedersen
Journal of Alzheimer's Disease 52 (2), 433-449, 2016
932016
Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration
MH Andersen, J Gehl, S Reker, LØ Pedersen, JC Becker, P Geertsen, ...
Seminars in cancer biology 13 (6), 449-459, 2003
852003
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
J Nielsen, J Pedersen, J Gerwien, K Bay, L Pedersen, M Leist, M Geist, ...
US Patent App. 10/612,665, 2004
842004
The interaction of beta 2‐microglobulin (β2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse β2m
LØ Pedersen, A Stryhn, TL Holtet, M Etzerodt, J Gerwien, MH Nissen, ...
European journal of immunology 25 (6), 1609-1616, 1995
801995
Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules
I Joosten, MHM Wauben, MC Holewijn, K Reske, LØ Pedersen, ...
International immunology 6 (5), 751-759, 1994
731994
A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules
AC Olsen, LØS Pedersen, AS Hansen, S Buus, MH Nissen, M Olsen, ...
European journal of immunology 24 (2), 385-392, 1994
691994
Molecular Characterization of the Di-leucine-based Internalization Motif of the T Cell Receptor (∗)
J Dietrich, X Hou, AMK Wegener, LØ Pedersen, N Ødum, C Geisler
Journal of Biological Chemistry 271 (19), 11441-11448, 1996
681996
Receptor-ligand interactions measured by an improved spun column chromatography technique A high efficiency and high throughput size separation method
S Buus, A Stryhn, K Winther, N Kirkby, LØ Pedersen
Biochimica et Biophysica Acta (BBA)-General Subjects 1243 (3), 453-460, 1995
681995
Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanism
A Stryhn, LØ Pedersen, A Holm, S Buus
European journal of immunology 30 (11), 3089-3099, 2000
642000
The system can't perform the operation now. Try again later.
Articles 1–20